Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 204
Ph III recruiting: 21
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 301–350 of 461 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07369986	Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer(IMMUNE-SAVE)	not yet recruiting	Phase 2	30	Women's Hospital School Of Medicine Zhejiang UniversityOTHER	0	Jan 27, 2026	clinicaltrials
NCT06846775	The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study	recruiting	—	120	University of AarhusOTHER